Christine Bellon

Christine Bellon

General Counsel at BEAM THERAPEUTICS INC.

Net worth: 3 M $ as of 31/08/2026

61 year
Health Technology
Consumer Services
Finance

Profile

Christine Bellon is currently a Trustee at the Museum of Science and Chief Legal Officer at Beam Therapeutics, Inc. Formerly, Dr. Bellon was Patent Counsel at Wyeth LLC; Secretary, Vice President & General Counsel at Forma Therapeutics, Inc. from 2017 to 2019; Assistant General Counsel at Infinity Pharmaceuticals, Inc.; VP-Intellectual Property & Legal Affairs at Hydra Biosciences, Inc.; Attorney at Fish & Richardson PC; Secretary & Vice President-Legal Affairs at Blueprint Medicines Corp.; and Senior Vice President-Legal Affairs at Relay Therapeutics, Inc. from 2016 to 2017.
Education includes a doctorate from Massachusetts Institute of Technology, an undergraduate degree from Yale University, and a graduate degree from Columbia Law School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/04/2026 109,711 ( 0.11% ) 3 M $ 31/08/2026

Christine Bellon active positions

CompaniesPositionStart
BEAM THERAPEUTICS INC. General Counsel 01/04/2019
Director/Board Member -

Former positions of Christine Bellon

CompaniesPositionEnd
General Counsel 01/04/2019
RELAY THERAPEUTICS, INC. General Counsel 01/10/2017
BLUEPRINT MEDICINES CORPORATION General Counsel 02/09/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Christine Bellon's experience

Training of Christine Bellon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Christine Bellon
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!